Campus Recruitment
CATEGORY
[Product Name] Urofollitropin for Injection [Composition] A preparation of Urofollitropin, which is a sterile lyophilized form after adding appropriate excipient. [Indication] 1. Treatment of anovulation (include Polycystic ovary syndrome) and be invalid to Clomiphene Citrate. 2. To assist ovarian hyperstimulation of reproductive technology.
View more
Leuprorelin Acetate Microspheres for Injection
[Product Name] Leuprorelin Acetate Microspheres for Injection. [Composition] Main ingredients: copolymer of leuprorelin acetate and glycolide lactide (25:75), gelatin, D-mannitol. [Indication] 1. Endometriosis 2.Hysteromyoma reduce and/or improve hysteromyoma accompanied by hypermenorrhea, hypogastralgia, back pain and anaemia and etc. 3. Premenopausal breast cancer with estrogen receptor positive. 4. Prostate cancer. 5. Central precocious puberty.
View more
Kanamycin (as sulfate) Solution for Injection
[Product Name] Kanamycin (as sulfate) Solution for Injection [Qualitative and Quantitative Composition] 500mg: 1 ampoule of 2 mL contains 500 mg kanamycin (as sulfate) 1000mg: 1 ampoule of 3 mL contains 1000mg kanamycin (as sulfate) [Package] 500 mg: 1 ampoule of 2 ml sterile solution for injection, 10 ampoules in 1 paper box 1000 mg: 1 ampoule with 3 ml sterile solution for injection, 10 ampoules in 1 paper box
View more
[Product Name] Menotropins for Injection [Composition] Menotropins for Injection is a preparation of glycoprotein gonadotropins, extracted from the urine of postmenopausal women. Each vial contains 75 International Units (IU) of follicle-stimulating hormone (FSH) activity and 75 IU of luteinizing hormone (LH) activity.
View more
[INDICATlONS] Benefiting vital energy and strengthening physique. It is for the treatment of weakness and tiredness, lassitude, spontaneous sweating, vertigo which are caused by the energy deficiency of lung and spleen. It is also the adjuvant therapy for the patients of lung cancer and stomach cancer with the above symptoms. [DOSAGE AND ADMINISTRATION] Intravenous drip of 250 ml once a day with a course of 21 days, for combining with chemotherapy. The treatment starts 3 days before the chemotherapy, and be synchronized ended with chemotherapy. [ADVERSE REACTIONS] 1. The patients with non-deficiency of vital energy may have mild bleeding after administration. 2. Small number of patients may have low fever, stomatitis and sleepiness after administration 3. Occasionally, rash, injection site pain, aversion to cold, chills, high fever, vomit, chest distress, palpitation may occur to patients after administration.
View more
Human Chorionic Gonadotrophin for Injection
[Product Name] Human Chorionic Gonadotrophin for Injection [Composition] A preparation of Chorionic Gonadotrophin, which is a sterile lyophilized form after adding appropriate excipient. The titer is 80%-125% of the labelled amount.
View more